215 related articles for article (PubMed ID: 12576456)
1. RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response.
Burger H; Foekens JA; Look MP; Meijer-van Gelder ME; Klijn JG; Wiemer EA; Stoter G; Nooter K
Clin Cancer Res; 2003 Feb; 9(2):827-36. PubMed ID: 12576456
[TBL] [Abstract][Full Text] [Related]
2. Combination of 7-
Chen Y; Li X; Shi L; Ma P; Wang W; Wu N; Gan Y; Han X; Huang S; Kang X; Liu S; Zhen Y
Aging (Albany NY); 2022 Sep; 14(17):7156-7169. PubMed ID: 36107024
[TBL] [Abstract][Full Text] [Related]
3. NAT10-mediated mRNA N4-acetylcytidine modification of MDR1 and BCRP promotes breast cancer progression.
Zhao CC; Sun X; Chen J; Geng BD
Thorac Cancer; 2024 Apr; 15(10):820-829. PubMed ID: 38409918
[TBL] [Abstract][Full Text] [Related]
4. APC Loss Prevents Doxorubicin-Induced Cell Death by Increasing Drug Efflux and a Chemoresistant Cell Population in Breast Cancer.
Stefanski CD; Arnason A; Maloney S; Kotsen J; Powers E; Zhang JT; Prosperi JR
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108784
[TBL] [Abstract][Full Text] [Related]
5. Role of Cys-603 in dimer/oligomer formation of the breast cancer resistance protein BCRP/ABCG2.
Kage K; Fujita T; Sugimoto Y
Cancer Sci; 2005 Dec; 96(12):866-72. PubMed ID: 16367905
[TBL] [Abstract][Full Text] [Related]
6. Ensemble Machine Learning Approaches Based on Molecular Descriptors and Graph Convolutional Networks for Predicting the Efflux Activities of MDR1 and BCRP Transporters.
Adachi A; Yamashita T; Kanaya S; Kosugi Y
AAPS J; 2023 Sep; 25(5):88. PubMed ID: 37700207
[TBL] [Abstract][Full Text] [Related]
7. Low heritability in pharmacokinetics of talinolol: a pharmacogenetic twin study on the heritability of the pharmacokinetics of talinolol, a putative probe drug of MDR1 and other membrane transporters.
Matthaei J; Tzvetkov MV; Gal V; Sachse-Seeboth C; Sehrt D; Hjelmborg JB; Hofmann U; Schwab M; Kerb R; Brockmöller J
Genome Med; 2016 Nov; 8(1):119. PubMed ID: 27825374
[TBL] [Abstract][Full Text] [Related]
8. Origin of multidrug resistance in cells with and without multidrug resistance genes: chromosome reassortments catalyzed by aneuploidy.
Duesberg P; Stindl R; Hehlmann R
Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11283-8. PubMed ID: 11553793
[TBL] [Abstract][Full Text] [Related]
9. Coagulation factor V in breast cancer: a p53-regulated tumor suppressor and predictive marker for treatment response to chemotherapy.
Lind SM; Sletten M; Hellenes M; Mathelier A; Tekpli X; Tinholt M; Iversen N
J Thromb Haemost; 2024 Jun; 22(6):1569-1582. PubMed ID: 38382738
[TBL] [Abstract][Full Text] [Related]
10. CA 15-3 is predictive of response and disease recurrence following treatment in locally advanced breast cancer.
Al-azawi D; Kelly G; Myers E; McDermott EW; Hill AD; Duffy MJ; Higgins NO
BMC Cancer; 2006 Sep; 6():220. PubMed ID: 16953875
[TBL] [Abstract][Full Text] [Related]
11. The breast cancer coagulome in the tumor microenvironment and its role in prognosis and treatment response to chemotherapy.
Tinholt M; Tekpli X; Torland LA; Tahiri A; Geisler J; Kristensen V; Sandset PM; Iversen N
J Thromb Haemost; 2024 May; 22(5):1319-1335. PubMed ID: 38237862
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of multidrug-resistance mdr1 gene expression in head and neck cancer by real-time RT-PCR.
Tseng CP; Cheng AJ; Chang JT; Tseng CH; Wang HM; Liao CT; Chen IH; Tseng KC
Jpn J Cancer Res; 2002 Nov; 93(11):1230-6. PubMed ID: 12460464
[TBL] [Abstract][Full Text] [Related]
13. Germline genetic variants in ABCB1, ABCC1 and ALDH1A1, and risk of hematological and gastrointestinal toxicities in a SWOG Phase III trial S0221 for breast cancer.
Yao S; Sucheston LE; Zhao H; Barlow WE; Zirpoli G; Liu S; Moore HC; Thomas Budd G; Hershman DL; Davis W; Ciupak GL; Stewart JA; Isaacs C; Hobday TJ; Salim M; Hortobagyi GN; Gralow JR; Livingston RB; Albain KS; Hayes DF; Ambrosone CB
Pharmacogenomics J; 2014 Jun; 14(3):241-7. PubMed ID: 23999597
[TBL] [Abstract][Full Text] [Related]
14. Association between
Su JL; Wang CH; Kang HG; Zhang J; Wang BZ; Liu MR; Zhao J; Liu L
Oncol Lett; 2017 Sep; 14(3):3510-3514. PubMed ID: 28927106
[TBL] [Abstract][Full Text] [Related]
15. Clinical study of multi-drug resistance gene (MDR1) expression in primary ovarian cancer.
Wang S; Cai G
J Tongji Med Univ; 1998; 18(1):58-60. PubMed ID: 10806806
[TBL] [Abstract][Full Text] [Related]
16. Genetic effects and modifiers of radiotherapy and chemotherapy on survival in pancreatic cancer.
Zeng H; Yu H; Lu L; Jain D; Kidd MS; Saif MW; Chanock SJ; Hartge P; ; Risch HA
Pancreas; 2011 Jul; 40(5):657-63. PubMed ID: 21487324
[TBL] [Abstract][Full Text] [Related]
17. Expression and activity of multidrug resistance proteins in mature endothelial cells and their precursors: A challenging correlation.
Krawczenko A; Bielawska-Pohl A; Wojtowicz K; Jura R; Paprocka M; Wojdat E; Kozłowska U; Klimczak A; Grillon C; Kieda C; Duś D
PLoS One; 2017; 12(2):e0172371. PubMed ID: 28212450
[TBL] [Abstract][Full Text] [Related]
18. Association of
Justo-Garrido M; López-Saavedra A; Alcaraz N; Cortés-González CC; Oñate-Ocaña LF; Caro-Sánchez CHS; Castro-Hernández C; Arriaga-Canon C; Díaz-Chávez J; Herrera LA
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003293
[TBL] [Abstract][Full Text] [Related]
19. Prognostic role of multidrug resistance-associated protein 1 expression and platelet count in operable non-small cell lung cancer.
Fang L; Sheng H; Wan D; Zhu C; Jiang R; Sun X; Feng J
Oncol Lett; 2018 Jul; 16(1):1123-1132. PubMed ID: 30061938
[TBL] [Abstract][Full Text] [Related]
20. Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapy.
Cao J; Zhang Z; Zhou L; Luo M; Li L; Li B; Nice EC; He W; Zheng S; Huang C
MedComm (2020); 2023 Dec; 4(6):e427. PubMed ID: 38045829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
